A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 415 shares of AZN stock, worth $27,497. This represents 0.01% of its overall portfolio holdings.

Number of Shares
415
Previous 415 -0.0%
Holding current value
$27,497
Previous $32.4 Million 0.1%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$61.03 - $69.57 $6,469 - $7,374
-106 Reduced 20.35%
415 $28.1 Million
Q4 2023

Feb 08, 2024

BUY
$61.89 - $69.28 $32,244 - $36,094
521 New
521 $35.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Atlantic Edge Private Wealth Management, LLC Portfolio

Follow Atlantic Edge Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Edge Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Edge Private Wealth Management, LLC with notifications on news.